Ritonavir
NDC 65162-061, Ritonavir, tablet, from Amneal Pharmaceuticals LLC.
- Product NDC
- 65162-061
- Status
- Listed
- Labeler
- Amneal Pharmaceuticals LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA208890
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/65162-061 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RITONAVIR100 mg/1
Pharmacologic classes
Breast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 1A2 Inducers [MoA]; Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 2C19 Inducers [MoA]; Cytochrome P450 2C9 Inducers [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A Inducers [MoA]; Cytochrome P450 3A Inhibitor [EPC]; Cytochrome P450 3A Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; HIV Protease Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]; Protease Inhibitor [EPC]; UDP Glucuronosyltransferases Inducers [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 65162-061-06 | 65162006106 | 60 TABLET in 1 BOTTLE (65162-061-06) |
| 65162-061-32 | 65162006132 | 360 TABLET in 1 BOTTLE (65162-061-32) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/a32cb2e3-d4e5-4bbf-9d88-20b2b249e779
Use it
Look up 65162-061 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/65162-061 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 65162-061. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.